ImageneBio Inc(IMA)

$4.72—Stale · unknown old

WatchlistAsk SA Chart

ImageneBio Inc(IMA)

NASDAQ • Last print unknown ago

$4.72—Stale · unknown old

WatchlistAsk SA Chart Studio

IMA(IMA)

IMA

Next report

Nov 11 2026in 46 days

EPS estimate

($0.83)

Revenue estimate

—

EPS beats

9 of last 12

EPS surprise

Each report against the estimate that stood when it landed.

Nov 9 2023Aug 5 2026

Reported	EPS est	EPS actual	Surprise	Revenue est	Revenue actual	Surprise
Aug 5 2026	($0.98)	($0.63)	+35.5%	—	—	—
May 7 2026	($0.70)	($0.95)	-35.7%	—	—	—
Mar 5 2026	($1.45)	($0.62)	+57.2%	—	—	—
Nov 12 2025	($1.47)	($2.91)	-98.0%	—	—	—
Jul 24 2025	($0.14)	($0.06)	+57.1%	—	-$500000	—
May 8 2025	($0.21)	($0.18)	+14.3%	—	$800000	—
Mar 6 2025	($0.23)	($0.18)	+21.7%	$875000	—	—
Nov 7 2024	($0.27)	($0.21)	+22.2%	—	—	—
Aug 8 2024	($0.35)	($0.28)	+20.0%	—	—	—
May 13 2024	($0.41)	($0.33)	+19.5%	$2M	—	—
Mar 12 2024	($0.43)	($0.47)	-9.3%	$2M	$658000	-73.0%
Nov 9 2023	($0.43)	($0.40)	+7.0%	$3M	$1M	-58.2%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-57.47%

EPS—

FY2028

Rev-57.47%

EPS—

FY2029

Rev-57.47%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$340,244	$144,707	$61,544	$26,175	$21M
Low	$340,244	$144,707	$61,544	$26,175	$21M
High	$340,244	$144,707	$61,544	$26,175	$21M
EBITDA Avg	$-17M	$-16M	$-15M	$-18M	$-20M
Low	$-19M	$-28M	$-27M	$-18M	$-20M
High	$-15M	$-4M	$-3M	$-18M	$-20M
EBIT Avg	$-18M	$-17M	$-16M	$-18M	$-21M
Low	$-19M	$-28M	$-28M	$-18M	$-21M
High	$-16M	$-5M	$-4M	$-18M	$-21M
Net Income Avg	$-18M	$-17M	$-16M	$-18M	$-21M
Low	$-19M	$-28M	$-28M	$-18M	$-21M
High	$-16M	$-5M	$-4M	$-18M	$-21M
EPS Avg	$-3.22	$-3.48	$-3.75	$-3.30	$-3.80
Low	$-3.56	$-5.23	$-5.07	$-3.30	$-3.80
High	$-2.94	$-0.94	$-0.72	$-3.30	$-3.80
Analysts (Rev / EPS)	4 / 3	4 / 3	4 / 4	2 / 1	2 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBITDA Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBIT Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
Net Income Avg	$-13M	$-15M	$-13M	$-14M	$-15M	$-18M	$-12M	$-11M
Low	$-15M	$-16M	$-13M	$-14M	$-15M	$-18M	$-12M	$-11M
High	$-11M	$-12M	$-13M	$-14M	$-15M	$-18M	$-12M	$-11M
EPS Avg	$-0.80	$-0.91	$-0.79	$-0.84	$-0.93	$-1.10	$-0.75	$-0.71
Low	$-0.95	$-1.01	$-0.79	$-0.84	$-0.93	$-1.10	$-0.75	$-0.71
High	$-0.66	$-0.76	$-0.79	$-0.84	$-0.93	$-1.10	$-0.75	$-0.71
Analysts (Rev / EPS)	— / 3	— / 3	— / 1	— / 1	— / 1	— / 1	— / 2	— / 2

Earnings Call Transcripts

No earnings transcripts available for IMA

Transcripts may not be available for all companies

Explore More

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Strategy Focus List

Continuous multi-factor scoring & catalyst forensics

Market Movers

Today's biggest gainers and losers